Cancer care teams can end cancer-related lymphedema through prevention using SOZO® with L-Dex®
 

Let’s End Cancer-Related Lymphedema Through Prevention

Help Prevent Cancer-Related Lymphedema with a 30-second Test

SOZO® with L-Dex® delivers a precise fluid measurement reading quickly at the point of care. With periodic testing following cancer treatment, high-risk patients may be placed on a compression treatment protocol at the earliest possible stage to prevent the condition from progressing.

Request a Demo

Help Cancer Survivors Avoid Chronic Secondary Lymphedema

Nurse Practitioners

Introduce lymphedema prevention protocol immediately upon cancer diagnosis to prevent lymphedema progression and improve quality of life in cancer survivors.

Therapists

Provide more effective lymphedema treatment solutions for patients in the subclinical and stage 1 levels of lymphedema.

Medical Assistants

Get reliable, accurate noninvasive fluid measurement results in about 30 seconds using SOZO with L-Dex.

Elevated L-Dex® screen reading introducing a trigger for compression treatment

Detect Lymphedema Early and Intervene to Avoid Progression

Accurately Measure & Monitor Patient Fluid Status with L-Dex

SOZO incorporates L-Dex technology and bioimpedance spectroscopy (BIS) to quickly and easily provide an accurate measurement of fluid status – the L-Dex score. The L-Dex score represents the difference in the amount of extracellular fluid in an at-risk limb compared to an unaffected limb.

Request a Demo

MySOZO allows caregivers to access and share fluid measurement data

 

Capture & Share a Patient L-Dex Score in Seconds

SOZO allows medical staff in hospitals and cancer clinics to test patients at any location and immediately share that information with surgeons, oncologists, nurse practitioners, therapists and other members of the care team.

Request a Demo

Lymphedema progression can be reduced with early detection and compression therapy

 

Compression Garments Help Control Lymphedema Progression

L-Dex Testing Paired with Compression Therapy Can Reduce Lymphedema Progression

Clinical data shows that prescribed compression therapy combined with periodic L-Dex testing has been shown to reduce the progression of lymphedema by 95% in breast cancer patients1.

Lymphedema Prevention is Now Possible

A Lymphedema Prevention Program Gives Hope to Cancer Patients

Test

12

Test Upon Diagnosis & Periodically after Cancer Surgery

Once a patient has been diagnosed with breast cancer, melanoma, or pelvic area cancers, they will be tested by a member of your staff to record a baseline L-Dex score. The test itself takes less than 30 seconds and provides an ​immediate​ reading. After cancer surgery, patients should get tested every 3 months for the first 3 years, every 6 months for years 4 and 5, and annually thereafter2.

Trigger

9

Evaluate Elevated L-Dex Readings above the Baseline

Evidence shows that if a patient’s L-Dex score increases 6.5 or more from the baseline, that’s a “trigger” to evaluate the patient and initiate intervention1.

Treat

11

Apply Treatment to Reduce Lymphedema Progression

Treatment for patients diagnosed with early lymphedema, including standard compression garments worn at home for 4 weeks, 12 hours per day, has been shown to reduce the progression of lymphedema by 95% in breast cancer patients​1.

Recommend a Lymphedema Prevention Program for Your Cancer Clinic or Private Practice

ImpediMed has created a step-by-step playbook for lymphedema prevention to help caregivers administer the SOZO test and to escalate treatment if the L-Dex score indicates lymphedema may be developing. Download our guide to learn more about the advantages of adding a lymphedema prevention program.

Together, We Can End Cancer-Related Lymphedema

Contact us to learn about SOZO with L-Dex and the benefits of supporting a Lymphedema Prevention Program.

Request a Demo

  • References

    1. Ridner SH, et al. A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis. Ann Surg Oncol 2019; https://doi.org/10.1245/s10434-019-07344-5.

    2. Shah C, et al. Bioimpedance Spectroscopy for Breast Cancer Related Lymphedema Assessment: Clinical Practice Guidelines. The Breast Journal 2016;DOI: 10.1111/tbj.12647.